Metopirone Capsule, Gelatin Coated
Product Images NDC 76336-455

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metopirone (NDC 76336-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hra Pharma Rare Diseases, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Metopirone 01)

Chemical structure diagram of the active ingredient in METOPiRONE 250 mg by Laboratoire HRA Pharma, illustrating its molecular arrangement with pyridine rings and ketone functional group.*

FDA Label Image

Principal Display Panel (250 mg Bottle Carton)

Packaging label for METOPiRONE 250 mg capsules (Metyrapone), manufactured by Catalent Germany Eberbach GmbH for HRA Pharma Rare Diseases, France. The label indicates a quantity of 18 capsules per package and includes storage instructions at 15°C-25°C, with protection from heat and moisture. The NDC number 76336-455-18 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.